Related by context. All words. (Click for frequent words.) 59 Voraxaze 56 Emezine 56 Aloxi Injection 56 NEBIDO 56 RIGScan CR 55 telavancin NDA 55 Centralized Procedure 55 ANDA submission 55 VALOR trial 55 BLA submission 55 FACTIVE tablets 55 BLA filing 55 Biologic License Application BLA 55 Surfaxin lucinactant 55 Medidur FA 54 Plenaxis R 54 Rotarix R 54 ZEGERID Capsules 54 Premarket Approval 54 rThrombin 54 NDA resubmission 54 Exalgo 54 OraTest 54 LibiGel NDA 54 WHO prequalification 53 Urocidin TM 53 CORTOSS Bone Augmentation Material 53 Triage Stroke Panel 53 eCTD format 53 Biologics Licensing 53 GRAS notification 53 pixantrone NDA 53 PLAVIX ® 53 Biological License Application 53 Solzira 53 CHMP recommendation 53 Reclast Aclasta 52 Fodosine 52 liver resection surgeries 52 balsalazide tablet 52 Flutiform ™ 52 Alvesco R 52 MAA submission 52 Orathecin 52 Cellegesic 52 MGCD# clinical trials 52 Visian Toric ICL 52 premarket notification 52 FACTIVE R gemifloxacin 52 CIP TRAMADOL ER 52 EHT AGN 52 FDA Accelerated Approval 52 Daytrana TM 52 XiDay 52 CLIA waiver 52 IoGen 52 ZEGERID Powder 52 Stimuvax R 52 Somatuline R Autogel R 52 MethyPatch 51 Firazyr ® 51 Onsolis 51 SURFAXIN 51 Rhucin R 51 inspectional observations 51 Periostat R 51 Preotact 51 naronapride 51 eprodisate KIACTA TM 51 LUVOX CR 51 T Pred 51 Bepreve 51 Gestiva ™ 51 rolling Biologics License 51 THALOMID 51 APF# NDA 51 tramiprosate ALZHEMED TM 51 Galephar 51 FDA approvable letter 51 Exelbine NDA 51 sumatriptan injection 51 EGRIFTA 51 Cutanea 51 postmarket studies 51 BRILINTA 51 generic Copaxone 51 Gestiva TM 51 TKM Ebola 51 Junovan 51 lorcaserin NDA 51 CryoSeal FS System 51 Marketing Authorization Applications 51 eSVS MESH 50 postapproval 50 PREOS R 50 EGRIFTA TM 50 resultsof 50 zileuton CR 50 Flutiform TM 50 RAPTIVA R 50 STEDESA 50 Mycograb 50 Raptiva R 50 PerClot 50 Approvable letter 50 Velac 50 Increlex TM 50 Soliris eculizumab 50 gepirone ER 50 approvable letters 50 Promus Element stent 50 OraTest R 50 Rhucin ® 50 Vectibix panitumumab 50 share repurchase authorizations 50 Onco TCS 50 ThromCat 50 generic Lovenox 50 Shire BioChem Inc. 50 sNDA submission 50 Scivanta Medical Corporation 50 PROVIGIL 50 NASDAQ PGNX 50 Reloxin R 50 Complete Response 50 Periostat 50 Azzalure R 50 MEPACT 50 Prestara 50 SYCREST 50 Synerx 50 Certican 50 Praecis 50 dalbavancin 50 Kyowa Kirin 50 Tyvaso 50 Ceplene histamine dihydrochloride 50 alvimopan 50 oral methylnaltrexone 50 Zelrix 50 Sumavel DosePro 50 bazedoxifene 50 Kynapid 50 discloseable transaction 50 unapproved colchicine 50 Ceplene ® histamine dihydrochloride 50 RAPIACTA ® 50 BioGlue ® 50 Aclasta Reclast 50 Nebido 49 antibacterial therapeutics 49 PMA submission 49 blood thinner prasugrel 49 IND submission 49 Debt Settlement Agreements 49 PDUFA date 49 BREAKYL 49 Aflunov 49 Monovisc 49 risksassociated 49 Zenpep 49 BiDil XR 49 ENRICH trial 49 FIRAZYR 49 Zensana 49 Xenazine ® 49 StaphVax 49 SOLODYN 49 Subpart H 49 k Premarket Notification 49 Menaflex device 49 Exelbine 49 Vernakalant 49 WILEX 49 Transparency Directive 49 IND CTA 49 Daytrana ™ 49 AMPAKINE CX# 49 Nabi HB Intravenous 49 OFIRMEV 49 Nunn McCurdy breach 49 Fortigel 49 cervical cancer vaccine Cervarix 49 submit Biologics License 49 Metozolv ODT 49 Metabasis stockholders 49 Zytiga 49 Biologics License Application BLA 49 generic atorvastatin 49 CryoSeal 49 Biologics License Application 49 HepeX B 49 alogliptin NDA 49 APTIMA HPV assay 49 Realization Strategy 49 ISTODAX 49 Exelon Patch 49 Somatuline Depot 49 Esbriet pirfenidone 49 PD2i Analyzer 49 Value Enhancement Plan 49 talactoferrin 49 XIAFLEX ™ 49 Rhucin 49 ANDA applicant 49 Sycrest 49 Certriad 49 ATryn ® 49 Lumizyme 49 Ultimate Squeegee 49 CONBRIZA 49 MONOVISC 49 Zalbin 49 Marketing Authorisation Application MAA 49 Bionutrics 49 Aphthasol R 49 Medigen 49 sumatriptan DosePro 49 BugOil R 49 HCT Ps 49 JOULFERON 48 PIX# trial 48 ENTEREG ® 48 FLECTOR ® Patch 48 Phase III TRIST 48 rPA vaccine candidate 48 PRIPs 48 Kombiglyze XR 48 MTP Ventures 48 MHLW 48 sNDAs 48 KRYSTEXXA 48 Neurogen stockholders 48 Frova ® 48 Daytrana ® 48 indiplon capsules 48 iChem VELOCITY 48 generic Norvasc 48 Marketing Authorization Application 48 Nasdaq OSCI 48 IPM Wound Gel 48 Loramyc R 48 Mepact 48 Combidex 48 CRMD# 48 AERx iDMS 48 Zeneus 48 Glassia 48 #D#C# 48 Firdapse 48 antibiotic telavancin 48 Loramyc TM 48 Notified Bodies 48 Biophan patent 48 biosimilar medicines 48 exercisability 48 Marketing Authorizations 48 OLEPTRO 48 OrCel R 48 Orphan Drug designations 48 SILENOR ™ 48 SEASONALE 48 BYDUREON 48 Domilens 48 Fluarix vaccine 48 Tekamlo 48 Thalidomide Pharmion 48 NDA submission 48 TRISENOX 48 Loramyc ® 48 ICH guidelines 48 Rectogesic 48 rhThrombin 48 Arxxant 48 Somatuline R Depot 48 InterfeRx 48 ZADAXIN ® 48 Marketing Authorisation 48 GeoVax AIDS vaccine 48 motavizumab 48 Allovectin 7 r 48 Evoltra 48 DPX Survivac 48 cGMPs 48 withrespect 48 Lebowa transaction 48 Esbriet ® 48 Tysabri Elan 48 BLA resubmission 48 Not Approvable 48 LidoPAIN SP 48 MyVax 48 NeoRx Corporation 48 Stonewall BDL 48 ThyroTest R 48 SynthRx 48 Amyvid 48 ComfortScan system 48 severe hypercholesterolemia 48 Loramyc ™ 48 supplemental Biologics License Application 47 vitro molecular diagnostic 47 Actimmune R 47 PMPRB 47 Marketing Authorization Application MAA 47 methylnaltrexone 47 Purifine enzyme 47 supplemental biologics 47 Bioaccelerate compounds under 47 Zingo TM 47 Dacogen injection 47 DC Bead 47 BENLYSTA 47 obesity pill Acomplia 47 Sular formulation 47 ZALBIN 47 EITF #-#-# 47 Onrigin 47 PCA3 test 47 faropenem 47 Thelin TM 47 ANDA approvals 47 OMP designation 47 apaziquone 47 Solvency II directive 47 AnorMED expectation 47 PRECISE Trial 47 CallWave stockholders 47 Fluviral 47 EGRIFTA ™ 47 ADVEXIN therapy 47 novel therapeutic modality 47 adopting IFRS 47 PREOS 47 DepoBupivacaine TM 47 nasal Cold Remedy 47 Fusilev 47 ASX UNS 47 jurisdictional thresholds 47 Eloxatin ® 47 TRISENOX ® 47 OTC ZEGERID 47 IND Investigational New 47 phase IIb trial 47 ESTRASORB R 47 Ketotransdel 47 bioresearch monitoring 47 SCHWARZ PHARMA 47 GEM #S 47 k premarket 47 CUSF application 47 bardoxolone 47 PrevOnco ™ 47 histamine dihydrochloride 47 Amlodipine Besylate Tablets 47 TSX SHQ 47 covenant ratios 47 Oxandrin 47 FDAAA 47 Orthopedic Advisory Panel 47 Biologics License Applications 47 OMAPRO 47 Investigational Device Exemption 47 Sanctura XR 47 XIAPEX 47 SPARLON 47 PhotoCure 47 PDUFA 47 Saforis 47 Contrave NDA 47 Evoltra TM 47 Lauren Silvernail 47 Application BLA 47 Complete Response letter 47 requisite stockholder 47 pediatric exclusivity 47 JUVISTA 47 Ravelston Entities 47 Oscient Pharmaceuticals 47 Menaflex implant 47 NanoCrystal technology 47 Folotyn 47 Pennsaid Plus 47 GRALISE 47 NASDAQ Listing Qualification 47 Ofirmev 47 Oracea ® 47 Nuedexta 47 Fanapt ® 47 REPEL CV 47 assigned PDUFA 47 TheraCIM 47 SILENOR TM 47 redomiciliation 47 Opana ER 47 IntraBiotics 47 postmarketing studies 47 ZEGERID Chewable Tablets 47 anidulafungin 47 Rezonic 47 FluINsure 47 alogliptin 47 rhLF 47 NASDAQ INGN 47 postmarketing surveillance 47 EOBR mandate 47 Metricath Gemini 47 BioThrax ® 47 Synvisc One 47 RCEs 47 heterozygous FH 47 hoFH 47 GLASSIA 47 LUMIGAN R 47 LUVENIQ 47 Lasertel subsidiary 47 Viviant 47 fund BioSante LibiGel 47 dirucotide 47 Civacir 47 SILENOR 47 Nycomed GmbH 47 Lamfalussy process 47 pulls Darvon painkiller 47 Omigard 47 GTC recombinant human 46 PD2i Cardiac Analyzer 46 MacroChem Corporation 46 Transkaryotic Therapies TKTX 46 successfully commercialize Iluvien 46 Iusacell Celular 46 Complete Response Letter CRL 46 sBLA 46 molecular entities NMEs 46 SuperStitch ® 46 Firazyr 46 Vimpat ® lacosamide 46 PROPEL trial 46 CORTOSS 46 Vibativ 46 AMID Stapler ™ 46 Bronchitol 46 Silenor NDA 46 Toric ICL 46 Auxilium Pharma 46 Pulsys 46 HalcyGen 46 postmarket surveillance 46 notifiable transaction 46 CAMPATH 46 Cladribine 46 TriActiv 46 Prednisporin 46 Doribax 46 minimally dilutive 46 La.Code Crim.P. art 46 Neuradiab 46 CIP Fenofibrate 46 Multiferon R 46 ONTAK 46 Zor Pharmaceuticals 46 JunJing III 46 rPA anthrax vaccine 46 PrevOnco 46 DATES Comments 46 orphan designation 46 AnGes 46 offuture 46 self affirmed GRAS 46 transcervical sterilization 46 SUMAVEL 46 ORTHOVISC mini 46 LO LOESTRIN FE 46 SparVax 46 ACCLAIM II 46 Soliris TM eculizumab 46 SOLODYN R 46 Oravig 46 Increlex R 46 dacetuzumab collaboration 46 MVLWB 46 Marketing Authorisation Application 46 LDTs 46 Allovectin 7 46 HuMax CD4 46 Previstage TM GCC 46 Angioblast 46 midstage studies 46 Arzerra ofatumumab 46 UVIDEM 46 BioGlue R 46 PEARL SC 46 Velcade bortezomib 46 Sanvar R 46 Moxatag 46 FAS# R 46 Paris IPN 46 LUCASSIN 46 Orapred ODT 46 biosurgical 46 CHMP opinion 46 TAXUS Element Stent System 46 CoStar stent 46 ATryn R 46 Pre IND 46 Lexiscan TM 46 Concurso Plan 46 Miikana Therapeutics 46 severe dermatologic toxicities 46 Marketing Authorization 46 miconazole MBT 46 Vimpat R 46 ZDP Shares 46 LeadDiscovery 46 Synerx Pharma 46 iii Cubist 46 BEMA Fentanyl 46 acquire Medafor 46 Intermezzo ® NDA 46 Prepandrix 46 Nasdaq VRTX 46 Loramyc 46 #L Sterilizer 46 Glybera R 46 Surfaxin LS 46 Angiox 46 Emselex 46 Irinotecan Hydrochloride Injection 46 Gralise 46 sNDA filing 46 Unifill syringe 46 Provecta 46 HepaGam B 46 StaphVAX 46 ANDA filings 46 Factive 46 Icatibant 46 RISDP 46 PROLACRIA ™ 46 THELIN 46 itsbusiness 46 Humanitarian Device Exemption 46 ZEFTERA ™ 46 post menopausal osteoporosis 46 OvaRex ® MAb 45 Fast Track designations 45 Breviary prayer book 45 Hedgehog antagonist 45 hypersensitivity allergic reactions 45 Sancuso 45 mesylate tablets approved 45 Aplenzin 45 miRNA therapeutics 45 Xolegel 45 Eligard R 45 pralatrexate 45 ELIQUIS 45 Primera Bioscience 45 IFRS changeover 45 Lumacan 45 Postmarket 45 Ceragenin 45 biogeneric drugs 45 User Fee Act 45 painkiller Prexige 45 Troxatyl TM 45 ASX PGL 45 Linjeta 45 ANDAs pending approval 45 ColorectAlert TM 45 BioSTAR R 45 Interpretative Communication 45 granted Ortec 45 Drug Adminstration 45 Exorbitant salaries 45 TEMODAL 45 Cintredekin besudotox 45 BrachySil 45 Prosaptide 45 covenant defaults 45 vitro diagnostic IVD 45 non accelerated filer 45 oral taxane 45 consents authorizations 45 bookbuilding process 45 MacroChem 45 Durata Therapeutics 45 Trobalt 45 Zelnorm Zelmac 45 FSP EITF #-#-# [002] 45 MFFO 45 Replagal TM 45 NYSE Amex HEB 45 Dexo 45 LUCENTIS r 45 CytoFabTM 45 Omnitrope 45 NASDAQ FLML 45 Monovisc TM 45 Dextofisopam 45 interdepartmental coordination 45 CUBICIN 45 Oral lyn 45 Mofcom 45 Rescula 45 intravenous acetaminophen 45 Acquisition Transaction 45 Sensipar 45 liposome formulations 45 Horizant 45 Extavia 45 Nasdaq INGN 45 SEBIVO 45 KRYSTEXXA ™ 45 Vernalis plc 45 SEA Directive 45 Relistor 45 Sebivo 45 CVac 45 IV acetaminophen 45 ONGLYZA ™ 45 regulatory 45 FavId 45 HSGP 45 Eligard ® 45 ourability 45 MDUFMA 45 Orazol 45 Cladribine Tablets 45 refranchising initiative 45 Nellix technology 45 Keppra XR 45 Atrigel 45 Cytokinetics specified 45 Tekturna Rasilez 45 Aryx 45 eprodisate Fibrillex TM 45 Shigamabs 45 Enhance Biotech 45 Phase lll 45 ENLIGHT 45 Rotarix ® 45 PolyHeme ® 45 Colleague infusion pump 45 faropenem medoxomil 45 Rapinyl 45 eTag assays 45 Vitaros 45 Fanapt TM 45 Nicox 45 regardingthe 45 NADiA ProsVue 45 lesinurad 45 Angiotech Entities 45 Lofexidine 45 FDAs 45 UCB Cimzia 45 reapproval 45 MK #B 45 TWYNSTA ® 45 premerger notification 45 Targretin capsules 45 Teflaro 45 propoxyphene containing 45 PRNewswire FirstCall Genta Incorporated 45 OMAPRO ™ 45 Barr ANDA 45 Promacta 45 Cinryze TM 45 StaphVAX R 45 PDUFA reauthorization 45 registrational studies 45 IsoTis stockholders 45 liprotamase 45 ColonSentry test 45 HuMax TAC 45 Oracea TM 45 NASDAQ Listing Rules 45 ATIR ™ 45 Crisa acquisition 45 Valortim TM 45 Vasovist 45 ICH E# 45 Progenta TM 45 generic Flomax 45 PRECISE trial 45 ZURICH AFX Novartis AG 45 commercialize DAVANAT ® 45 Encysive Pharmaceuticals Nasdaq ENCY 45 Insegia 45 Q#IR 45 NYSE Amex PTN 45 Premarket Approval PMA 45 Tracleer r 45 Replagal 45 KRYSTEXXA TM pegloticase 45 lender consents 45 InfoSpherix subsidiary 45 PROMACTA CARES 45 ADVENTRX 45 Alnylam #x# 45 NitroMed BiDil 45 Dynepo TM 45 GRAS affirmation 45 Rhucin ® recombinant 45 OncoVEX 45 Dendreon Provenge 45 peripheral vascular stent 45 AMP demerger 45 PentaStaph 45 thetransaction 45 Linjeta TM 45 enoxaparin sodium injection 45 paliperidone palmitate 45 Solasia 45 ELEVESS 45 Accelerated Approval 45 Orapred 44 Shire velaglucerase alfa 44 Angiomax bivalirudin 44 generic Lipitor 44 SkyePharma PLC LSE SKP 44 Meldex 44 regarding Heska 44 Gleevec Glivec 44 PLK1 SNALP 44 Nasdaq NPSP announced 44 Alnara Pharmaceuticals 44 FDA Approvable Letter 44 Oncosphere 44 Belgian drugmaker UCB 44 Drug Submission 44 Nasdaq PCYC 44 KYNAPID 44 eCTD submission 44 FDA Complete Response 44 intravenous AAT 44 Xifaxan rifaximin 44 Pennsaid R 44 Ampligen r 44 DMEPOS supplier 44 R sipuleucel T 44 Premarket Notification 44 Linjeta ™ 44 Nascobal 44 Metformin GR 44 KRS #A.# [001] 44 Prolacria 44 Mutual Recognition Procedure 44 Gentamicin Surgical Implant 44 Therapeutic Goods Administration TGA 44 Zactima 44 Miikana 44 CytoFab 44 APEX AMI trial 44 OncoGenex Technologies 44 Vimovo 44 BioDelivery Sciences 44 BEXXAR 44 Fanandakis 44 Nivestim 44 ruxolitinib 44 ReCell 44 Decentralized Procedure 44 Evoltra ® 44 thorough QT 44 Clinical Trials Directive 44 KRYSTEXXA TM 44 Movectro 44 DRAXIS 44 KIACTA TM 44 including withoutlimitation 44 Joulferon 44 SAR# [004] 44 PDEIS 44 Davanat 44 Phase IIa clinical trials 44 ocular allergies 44 Xinlay 44 Tramadol ER 44 Canvaxin 44 biosimilar versions 44 FDA 44 CE Conformité Européenne 44 Omapro 44 transmucosal delivery system 44 Exon Florio 44 Iluvien ® 44 Virium 44 ECMR 44 Adenuric R 44 vinorelbine emulsion 44 ourbusiness 44 NMTC Program 44 Biologic License Application 44 CAP ROE 44 Zavesca r 44 REPLAGAL 44 Stedesa 44 MAXY alpha 44 Elevess 44 Psivida 44 Expedited Review 44 MyVax personalized immunotherapy 44 Hematide ™ peginesatide 44 Amending Directive 44 Multiferon 44 CDP# 44 EDSP 44 CELVAPAN H#N# 44 VALSTAR 44 Reloxin 44 CLIA Waiver 44 antiinfective 44 Ruconest 44 Substantial Issuer Bid 44 NP #-# requesting 44 Fortesta 44 CLIA certification 44 Pfizer inhaled insulin 44 Ixempra 44 Unifill TM syringe 44 MYLOTARG 44 Dermylex TM 44 SYMMETRY trial 44 orphan medicinal 44 inhaled AAT 44 Testim 44 EU Transparency Directive 44 Generex Oral lyn tm 44 Phase IIb clinical trials 44 UKIPO 44 Synvisc ONE 44 Inc. Nasdaq NSTK 44 FSP #-# 44 PROMACTA ® 44 rALLy trial 44 Taxus Liberte 44 Brinavess 44 Acetavance TM 44 Raptiva efalizumab 44 Severe hypersensitivity reactions 44 Applications ANDA 44 Glaxosmithkline plc GSK 44 FDA Modernization Act 44 Flutiform 44 ACAM# smallpox vaccine 44 FASTx TM 44 Civil Contingencies Bill 44 APEX AMI 44 Novartis AG Galvus 44 Arikace 44 EPA ToxCast 44 Troxatyl 44 Zavesca 44 anterior capsulotomy 44 Vertex Pharma 44 Oryx Pharmaceuticals 44 Urokinase 44 Adcirca 44 Afresa 44 Zevtera 44 Biogen Idec Tysabri 44 noninvasive prenatal 44 FDA Advisory Panel 44 Phase Ib study 44 FlutiformTM 44 Alnara 44 HYVISC R 44 Market Authorization Application 44 Ranbaxy Laboratories Ltd. #.BY 44 COLLEAGUE infusion pumps 44 requestor petitioner 44 GED aPC 44 Aryx Therapeutics 44 Evoltra R 44 voclosporin 44 Pruvel 44 MHPAEA 44 NYSE MIM MID 44 fusion enhancers 44 GLASSIA ™ 44 Mucotrol 44 oral alitretinoin 44 Protalix BioTherapeutics 44 Dr. Gulfo 44 blood thinner Exanta 44 Rasilez HCT 44 recombinant antithrombin product 44 Eligard 44 Amoxicillin PULSYS Phase III 44 Graniz Loan 44 AzaSite Plus 44 Resubmission 44 Vancocin 44 Meda STO MEDAA 44 Entereg alvimopan 44 AVINZA ® 44 SynX 44 Amlodipine Besylate 44 Zensana TM 44 MediWound 44 Impax generic 44 Heap Leach Project 44 Indiplon 44 Pillar5 44 bilastine 44 Inspire Pharma 44 BEMA TM Fentanyl 44 midstage trials 44 Temporary Framework 44 reexamination certificate 44 prudential regulations 44 Recapitalisation Proposal 43 Kosan dependence 43 Eurand NV EURX 43 Phase IIb III 43 optionholder 43 Subpart E 43 SkyePharma Plc 43 QbD 43 Zemiva TM 43 ColonSentry TM test 43 Taiho Pharmaceutical 43 Akela Pharma 43 prGCD 43 Amitiza ® 43 recombinant thrombin 43 Canaccord Relief Program 43 Tostrex 43 Nasdaq VPHM 43 Montaur 43 SemGroup LP SemGroup 43 Ceragenin TM technology 43 Evithrom 43 adrenergic regulation 43 Preotact R 43 Phase #b/#a 43 Oncoscience AG 43 Surface Specialties acquisition 43 HCV antiviral 43 resubmission 43 P#X# antagonist 43 Simdax 43 Meritage Pharma 43 Ventrus 43 BLAs 43 thecompletion 43 KIID 43 IV APAP 43 NDA BLA 43 Inc. Nasdaq DSCO 43 European Medicines Evaluation 43 Kerastick 43 MOZOBIL 43 FAS#R 43 SFAS# R 43 Luramist 43 Resolor 43 Preos 43 lucinactant 43 supplemental EIR 43 Approval Supplement 43 Basilea Toctino R 43 MEZAVANT 43 Helvea analyst Olav Zilian 43 Bellus Health 43 NYSE Amex ILI 43 Turbo Tandem 43 daily bactericidal antibiotic 43 Dyloject TM 43 FFDCA 43 approvability 43 Market Approval PMA 43 Allovectin 7 ® 43 Somatuline Autogel 43 Bocenor 43 Aegerion 43 BioDelivery 43 KIACTA ™ 43 Genentech Roche 43 BioSTAR ® 43 gene spliced foods 43 Visudyne R 43 Hatch Waxman Amendments 43 commercialization milestones 43 velaglucerase alfa 43 Arranon 43 Zemplar Capsules 43 UCB Pharma SA 43 Eliquis 43 egX Canada 43 Stavzor 43 Company TSX FNI 43 Krystexxa 43 NASDAQ GPCB today 43 FSP FAS #-# 43 Nasdaq SVNT 43 Enjuvia